Indications for anticoagulant or antiplatelet therapy

This list is not comprehensive and is intended as a guide to reflect the current use of these drugs in the UK population. Conditions for which the new drugs in particular are licensed are subject to change.

a Further combinations are possible if the patient has multiple indications.
b STEMI: ST segment elevation myocardial infarction
c Rivaroxaban is licensed for acute coronary syndrome (co-administered with aspirin alone or with aspirin plus clopidogrel or ticlopidine) and coronary artery disease or peripheral artery disease (co-administered with aspirin).